Podcast: Driving Drug Development Innovation Through Patient Centricity

November 18, 2019 Patty Collinsworth

Driving Drug Development Innovation Through Patient Centricity

Thought Leaders:

Sy Pretorius, MD, Chief Medical & Scientific Officer, PAREXEL
Alberto Grignolo, PhD, Corporate Vice President, PAREXEL

August 30, 2018

The Innovation Imperative: The Future of Drug Development, is a recent data-driven report developed and released by The Economist Intelligence Unit and commissioned by Parexel. The report examines drug development today and evaluates innovations that can accelerate clinical trials, increase likelihood of launch and patient access and improve the productivity of drug development. The report sought to quantify, for the first time, how four types of drug development innovations– patient-centric, adaptive, precision medicine and real-world data trials – can drive sustainability in drug development.

This podcast will specifically explore patient-centric trials as a key innovation in drug development that can drive faster recruitment, lead to improved research outcomes that are relevant and meaningful to patients and enable participation in research that is convenient as possible.

To listen: https://www.pharmavoice.com/podcasts/patient-centricity/

Previous Article
Capturing the patient voice in market access communications
Capturing the patient voice in market access communications

Patients have unique perspectives on their conditions that, when incorporated into value communicatio...

Next Article
The Ins and Outs of Incorporating Patient Centricity in Drug Development
The Ins and Outs of Incorporating Patient Centricity in Drug Development

This article was original published in Pharmaceutical Executive Magazine. ...